Overexpression of AIOLOS inhibits cell proliferation and suppresses apoptosis in Nalm-6 cells

Zhuang,Yong; Li,Dong; Fu,Jinqiu; Shi,Qing; Lu,Yuanyuan; Ju,Xiuli

doi:10.3892/or.2013.2964

Overexpression of AIOLOS inhibits cell proliferation and suppresses apoptosis in Nalm-6 cells

Authors:
- Yong Zhuang
- Dong Li
- Jinqiu Fu
- Qing Shi
- Yuanyuan Lu
- Xiuli Ju
View Affiliations

Affiliations: Department of Pediatrics, Qilu Hospital, Shandong University, Ji'nan, Shandong 250012, P.R. China, Cryomedicine Laboratory, Qilu Hospital, Shandong University, Ji'nan, Shandong 250012, P.R. China
Published online on: December 31, 2013 https://doi.org/10.3892/or.2013.2964
Pages: 1183-1190

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The AIOLOS gene is important in the control of mature B-lymphocyte differentiation and proliferation. Previous research has shown that deregulated AIOLOS expression is associated with adult B-cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia in human patients. However, the function of AIOLOS in childhood B-cell precursor (BCP)-ALL is not fully understood. In the present study, Nalm-6 cells were divided into three groups: the untransfected control (UT), the lentiviral vector control (Lenti-Mock) and the AIOLOS-overexpressing (Lenti-AIOLOS) group. Lenti-AIOLOS Nalm-6 cells were constructed by lentiviral transduction, followed by cell proliferation assay, cell-cycle analysis and apoptosis assay, to evaluate the effects of AIOLOS on proliferation, cell cycle distribution and apoptosis of Nalm-6 cells in vitro. Moreover, the expression levels of genes associated with apoptosis and the cell cycle, as well as the transcription factors IKZF1 and NF-κB, were investigated by quantitative reverse transcription-polymerase chain reaction and western blot analysis. The results showed that the proliferation of Nalm-6 cells in the Lenti-AIOLOS group was reduced by 16% on day 8 compared with cells in the UT group (P>0.05). The reduction peaked at 29% on day 10 (P<0.05). The percentage of Nalm-6 cells in the G0/G1 phase increased from 70.4 (UT) to 84.1% (Lenti-AIOLOS) (P<0.01), and the S-phase cells decreased from 20.3 (UT) to 11.7% (Lenti-AIOLOS) (P<0.01). Total apoptotic cells significantly decreased in AIOLOS-transfected Nalm-6 cells (10.75%) compared with those in the Lenti-Mock (17.00%) or UT group (19.05%) (P<0.01). In particular, the difference between the groups in the percentage of late apoptotic cells was significant (2.85 vs. 7.95%; P<0.01). In addition, overexpression of AIOLOS resulted in upregulation of BCL-2 and downregulation of CCND3, BAX, IKZF1 and NF-κB. No changes were detected on C-MYC and P27. Our findings indicate that lentivirus-mediated overexpression of AIOLOS in Nalm-6 cells could inhibit cell proliferation, suppress cell apoptosis and arrest the cell cycle at the G0/G1 phase in vitro.

View Figures

View References

1	Eden T: Aetiology of childhood leukaemia. Cancer Treat Rev. 36:286–297. 2010. View Article : Google Scholar : PubMed/NCBI
2	Kaatsch P: Epidemiology of childhood cancer. Cancer Treat Rev. 36:277–285. 2010. View Article : Google Scholar
3	Howard SC, Metzger ML, Wilimas JA, Quintana Y, Pui CH, Robison LL and Ribeiro RC: Childhood cancer epidemiology in low-income countries. Cancer. 112:461–472. 2008. View Article : Google Scholar : PubMed/NCBI
4	Pui CH, Campana D and Evans WE: Childhood acute lymphoblastic leukaemia - current status and future perspectives. Lancet Oncol. 2:597–607. 2001. View Article : Google Scholar : PubMed/NCBI
5	Belson M, Kingsley B and Holmes A: Risk factors for acute leukemia in children: a review. Environ Health Perspect. 115:138–145. 2007. View Article : Google Scholar : PubMed/NCBI
6	Cobaleda C and Sanchez-Garcia I: B-cell acute lymphoblastic leukaemia: towards understanding its cellular origin. Bioessays. 31:600–609. 2009. View Article : Google Scholar : PubMed/NCBI
7	Kelley CM, Ikeda T, Koipally J, Avitahl N, Wu L, Georgopoulos K and Morgan BA: Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr Biol. 8:508–515. 1998. View Article : Google Scholar : PubMed/NCBI
8	Morgan B, Sun L, Avitahl N, Andrikopoulos K, Ikeda T, Gonzales E, Wu P, Neben S and Georgopoulos K: Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J. 16:2004–2013. 1997. View Article : Google Scholar : PubMed/NCBI
9	Georgopoulos K, Winandy S and Avitahl N: The role of the Ikaros gene in lymphocyte development and homeostasis. Ann Rev Immunol. 15:155–176. 1997. View Article : Google Scholar : PubMed/NCBI
10	Wang JH, Avitahl N, Cariappa A, Friedrich C, Ikeda T, Renold A, Andrikopoulos K, Liang L, Pillai S, Morgan BA and Georgopoulos K: Aiolos regulates B cell activation and maturation to effector state. Immunity. 9:543–553. 1998. View Article : Google Scholar : PubMed/NCBI
11	Nakase K, Ishimaru F, Avitahl N, Dansako H, Matsuo K, Fujii K, Sezaki N, Nakayama H, Yano T, Fukuda S, Imajoh K, Takeuchi M, Miyata A, Hara M, Yasukawa M, Takahashi I, Taguchi H, Matsue K, Nakao S, Niho Y, Takenaka K, Shinagawa K, Ikeda K, Niiya K and Harada M: Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia. Cancer Res. 60:4062–4065. 2000.PubMed/NCBI
12	Nuckel H, Frey UH, Sellmann L, Collins CH, Duhrsen U and Siffert W: The IKZF3 (Aiolos) transcription factor is highly upregulated and inversely correlated with clinical progression in chronic lymphocytic leukaemia. Br J Haematol. 144:268–270. 2009. View Article : Google Scholar : PubMed/NCBI
13	Billot K, Soeur J, Chereau F, Arrouss I, Merle-Beral H, Huang ME, Mazier D, Baud V and Rebollo A: Deregulation of Aiolos expression in chronic lymphocytic leukemia is associated with epigenetic modifications. Blood. 117:1917–1927. 2011. View Article : Google Scholar : PubMed/NCBI
14	Antica M, Cicin-Sain L, Kapitanovic S, Matulic M, Dzebro S and Dominis M: Aberrant Ikaros, Aiolos, and Helios expression in Hodgkin and non-Hodgkin lymphoma. Blood. 111:3296–3297. 2008. View Article : Google Scholar : PubMed/NCBI
15	Caballero R, Setien F, Lopez-Serra L, Boix-Chornet M, Fraga MF, Ropero S, Megias D, Alaminos M, Sanchez-Tapia EM, Montoya MC, Esteller M, Gonzalez-Sarmiento R and Ballestar E: Combinatorial effects of splice variants modulate function of Aiolos. J Cell Sci. 120:2619–2630. 2007. View Article : Google Scholar : PubMed/NCBI
16	Duhamel M, Arrouss I, Merle-Beral H and Rebollo A: The Aiolos transcription factor is up-regulated in chronic lymphocytic leukemia. Blood. 111:3225–3228. 2008. View Article : Google Scholar : PubMed/NCBI
17	Cooper AB, Sawai CM, Sicinska E, Powers SE, Sicinski P, Clark MR and Aifantis I: A unique function for cyclin D3 in early B cell development. Nat Immunol. 7:489–497. 2006. View Article : Google Scholar : PubMed/NCBI
18	Habib T, Park H, Tsang M, de Alboran IM, Nicks A, Wilson L, Knoepfler PS, Andrews S, Rawlings DJ, Eisenman RN and Iritani BM: Myc stimulates B lymphocyte differentiation and amplifies calcium signaling. J Cell Biol. 179:717–731. 2007. View Article : Google Scholar : PubMed/NCBI
19	Ma S, Pathak S, Mandal M, Trinh L, Clark MR and Lu R: Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression. Mol Cell Biol. 30:4149–4158. 2010. View Article : Google Scholar : PubMed/NCBI
20	Romero F, Martinez AC, Camonis J and Rebollo A: Aiolos transcription factor controls cell death in T cells by regulating Bcl-2 expression and its cellular localization. EMBO J. 18:3419–3430. 1999. View Article : Google Scholar : PubMed/NCBI
21	Narvi E, Nera KP, Terho P, Mustonen L, Granberg J and Lassila O: Aiolos controls gene conversion and cell death in DT40 B cells. Scand J Immunol. 65:503–513. 2007. View Article : Google Scholar : PubMed/NCBI
22	Kikuchi H, Yamashita K, Nakayama M, Toyonaga K, Tsuneyoshi I, Takasaki M and Nakayama T: Lacking of Aiolos accelerates pre-mature B cell apoptosis mediated by BCR signaling through elevation in cytochrome c release. Biochim Biophys Acta. 1793:1304–1314. 2009. View Article : Google Scholar : PubMed/NCBI
23	Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, Winandy S and Sharpe A: The Ikaros gene is required for the development of all lymphoid lineages. Cell. 79:143–156. 1994. View Article : Google Scholar : PubMed/NCBI
24	Sethi G, Ahn KS and Aggarwal BB: Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res. 6:1059–1070. 2008. View Article : Google Scholar : PubMed/NCBI
25	Ghadiri A, Duhamel M, Fleischer A, Reimann A, Dessauge F and Rebollo A: Critical function of Ikaros in controlling Aiolos gene expression. FEBS Lett. 581:1605–1616. 2007. View Article : Google Scholar : PubMed/NCBI